Genomic Vision is a publicly-traded company on the Euronext regulated market in Paris
Interview of Stéphane Altaba in the Journal des Biotechs presented by Pierre-Louis Germain (Ulysse Communication) and Laurent Grassin (Boursorama).
Interview of Aaron Bensimon for TV Finance in the “Enterprise and Innovation” channel
Interview of Aaron Bensimon in the Journal des Biotechs, presented by Pierre-Louis Germain (Ulysse Communication) and Laurent Grassin (Boursorama).
Interview of Aaron Bensimon in La Bourse et la Vie TV.
Interview of Frédéric Tarbouriech at the Salon de l’Actionnariat, by Guillaume Clément (Le Revenu).
Aaron Bensimon, CEO of Genomic Vision explains his company’s business activities, on the one side its traditional activity of developing diagnostics tests, and on the other side an LSR activity, i.e. the development of genetic tools for research laboratories. The announcement of the collaboration with the American company Editas, one of the leaders in genome publishing, made the title jump.
Interview de Stéphane Altaba pour la Bourse et la Vie TV, avec un retour sur le R&D Day de Genomic Vision organisé en Septembre 2017.
Molecular combing of DNA, a new paradigm in the detection of genetic diseases with Charles Caulliez, Director Corporate Business Development of Genomic Vision
Interview with Stéphane Altaba, VP Corporate Development of Genomic Vision following the collaboration agreement signed with AstraZeneca in oncology
Interview of Aaron Bensimon for La Bourse et la Vie TV, during the BioMed Event organized by CF&B Com.
Genomic Vision’s Investor Day interview with Aaron Bensimon
Interview of Aaron Bensimon in Le Grand Journal de New York, presented by Sabrina Quagliozzi, on BFM Business.
Interview with Aaron Bensimon on the occasion of the IPO of Genomic Vision, for L’Intégrale Bourse (BFM Business).
La presse en parle